Subscribe To
CARA / Cara Therapeutics: De-Risked And Extremely Attractive
CARA News
By Zacks Investment Research
August 7, 2023
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
Cara Therapeutics (CARA) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to lo more_horizontal
By GlobeNewsWire
July 24, 2023
Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new more_horizontal
By Seeking Alpha
July 14, 2023
Cara Therapeutics Faces Uncertainty Despite Potential Reimbursement Extension For Korsuva
Cara Therapeutics' Korsuva injection, approved for treating pruritus in adults with chronic kidney disease, may have its reimbursement period extended more_horizontal
By InvestorPlace
June 13, 2023
3 Small-Cap Stocks to Sell in June Before They Crash and Burn
Small-cap stocks, defined by a market capitalization between $300 million and $2 billion, can tempt investors looking for quick returns. However, thes more_horizontal
By Seeking Alpha
May 15, 2023
Cara Therapeutics, Inc. (CARA) Q1 2023 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ:CARA ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Matt Murphy - Manager, IR Christo more_horizontal
By Zacks Investment Research
May 15, 2023
Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates
Cara Therapeutics (CARA) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to lo more_horizontal
By MarijuanaStocks
May 1, 2023
Cara Therapeutics, Inc. (CARA) to Announce First Quarter 2023 Financial Results on May 15, 2023
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, more_horizontal
By Benzinga
March 14, 2023
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. more_horizontal